Related content

Neuroprotection with glatiramer acetate: evidence from the PreCISe trial

By Arnold Douglas   Narayanan Sridar   Antel Samson  

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1901-1906

Springer Publishing Company

Access to resources Recommend Favorite

Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis

By Neumann Helmut   Csepregi Antal   Sailer Michael   Malfertheiner Peter  

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 816-817

Springer Publishing Company

Access to resources Recommend Favorite

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

By Weber Martin S.  

Brain, Vol. 127, Iss. 6, 2004-06 ,pp. : 1370-1378

Oxford University Press

Access to resources Recommend Favorite

Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis

By Salama Hassan H.  

Brain, Vol. 126, Iss. 12, 2003-12 ,pp. : 2638-2647

Oxford University Press

Access to resources Recommend Favorite

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy

By Ziemssen T.  

Brain, Vol. 125, Iss. 11, 2002-11 ,pp. : 2381-2391

Oxford University Press

Access to resources Recommend Favorite